Ventas (VTR) Misses Q3 EPS by 1c, Beats on Revenues
Get Alerts VTR Hot Sheet
Price: $86.80 -0.22%
EPS Growth %: +14.3%
Financial Fact:
Medical office buildings: 158.27M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +14.3%
Financial Fact:
Medical office buildings: 158.27M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Ventas (NYSE: VTR) reported Q3 EPS of $0.44, $0.01 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $899.93 million versus the consensus estimate of $882.25 million.
- Earnings Growth and Enhanced Financial Strength
- Property Level Growth Across All Segments; Updated and Improved 2017 Guidance
- Over $600 Million of Strategic Dispositions with Gains Exceeding $500 Million
- Expansion of Attractive University-Based Life Science Business
For earnings history and earnings-related data on Ventas (VTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share